Tg(APOC3)2674Bres
Transgene Detail
|
|
| Symbol: |
Tg(APOC3)2674Bres |
| Name: |
transgene insertion 2674, Jan L Breslow |
| MGI ID: |
MGI:3703623 |
| Synonyms: |
Low exp (2674), low expressor, Tg line 2674 |
| Transgene: |
Tg(APOC3)2674Bres Location: unknown
|
| Alliance: |
Tg(APOC3)2674Bres page
|
|
| Strain of Origin: |
(C57BL/6J x CBA/J)F2
|
|
| Transgene Type: |
|
Transgenic (Inserted expressed sequence) |
| Mutation: |
|
Insertion
|
| |
|
Tg(APOC3)2674Bres expresses
1 gene
Transgene expresses:
| Organism |
Expressed Gene |
Homolog in Mouse |
Note |
| human |
APOC3 (345) |
|
|
|
| |
|
Mutation details: Male pronuclei of fertilized oocytes were microinjected with a transgenic construct comprising the human apolipoprotein C-III gene, including 2.5 kb of 5' and 1.1 kb of 3' flanking sequence. 1-2 copies of the transgene were estimated present per haploid genome by quantitative Southern blot analysis. Solution hybridization RNase protection analysis with a riboprobe representing the 3' untranslated region of human APOC3 demonstrated transgene-derived RNA in liver and intestine, but none in brain of transgenic mice. Electroimmunoanalysis with a human-specific anti-APOC3 antibody detected human APOC3 in plasma of mice hemizygous for the transgene at 3.15 +/- 0.3 mg/dl mice and in plasma of homozygous transgenic mice at 8.2 +/- 1.0 mg/dl.
(J:81184)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
| Original: |
J:81184 Ito Y, et al., Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice. Science. 1990 Aug 17;249(4970):790-3 |
| All: |
3 reference(s) |
|